Animal Health Biotechnology in the US - Market Research Report (2014-2029)
New York, United States
Last Updated: September 2024
NAICS OD4023Revenue
$14.0bn
Past 5-Year Growth
Profit
$X.Xbn
Employees
29,996
Businesses
197
Wages
$X.Xbn
Animal Health Biotechnology in the US industry analysis
Animal health biotechnology companies create products – vaccines, medications and food – that safeguard animals' health. Changing attitudes toward companion animals like dogs and cats encourage pet owners to pay premiums for these products. At the same, livestock producers see an invaluable benefit in biotech to protect their animals and investments. Innovative developments created by animal health biotechnology companies have shown the field's potential, leading investors to flock to animal health biotechnology companies. A rapidly expanding animal health market is leading industry-wide revenue to grow at an average annualized 3.1% over the past five years. It is expected to total $14.0 billion in 2024 when revenue will rise by an estimated 0.4%.
Trends and Insights
- Animal health biotech companies are increasingly involved in safeguarding animal health. Pet owners and livestock producers are willing to pay a premium to improve the well-being of their animals.
- Developments in vaccines and medications are transforming animal care. Animal health biotech companies are introducing innovative medications that are invaluable to veterinarians and livestock producers.
- Mid-Atlantic states are biotech hubs. Animal health leaders Zoetis and Merck drive biotech activity in the region.
- Patent protection limits price competition. Biotechnology companies with patent protection receive market exclusivity for their product, granting them pricing power.
Industry Overview
Market size and recent performance (2014-2029)
Industry revenue has grown at a CAGR of 3.1 % over the past five years, to reach an estimated $14.0bn in 2024.
Trends and Insights
Animal health becomes increasingly important to pet owners and livestock producers
- As more pet owners view their pets as a part of the family, rising concerns about their well-being and healthcare have increased owners' willingness to spend on pet medications and vaccines.
- Additional trends and insights available with purchase
Source: IBISWorld
Industry outlook (2024-2029)
Market size is projected to grow over the next five years.
Trends and Insights
A higher interest rate environment will threaten biotech performance
- Animal health biotechnology companies will continue to rely on capital to fund research and development (R&D). But, a higher cost of capital could shift investment activity moving forward.
Biggest companies in the Animal Health Biotechnology in the US
| Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
|---|---|---|---|---|
Zoetis Inc. | 4,955.5 | 1,736.1 | 35.0 | |
Merck & Co | 2,611.6 | 64.5 | 2.5 | |
CH Boehringer Sohn AG & Ko. KG | 971.3 | 226.3 | 23.3 |
To view the market share and analysis for all 3 top companies in this industry, view purchase options.
Products & Services Segmentation
Source: IBISWorld
Industry revenue is measured across several distinct product and services lines, including Medications and vaccines, Anti-infectives and Other. Medications and vaccines is the largest segment of the Animal Health Biotechnology in the US.
Trends and Insights
The development of biotech vaccines and medication creates invaluable benefits for animal health
- Animal health biotechnology companies develop vaccines and medications for companion pets and livestock to fight infection and other common ailments. Vaccines and medications are the most lucrative products for animal health biotech companies.
- More insights available in the full report
Widen you competitive advantage with related industries
Competitors
- There are no industries to display.
Complementors
- Livestock Production Support Services in the US
- Medical Device Manufacturing in the US
- Veterinary Services in the US
- Biotechnology in the US
International industries
- Global Biotechnology
- Scientific Research & Development in Canada
- Scientific Research Services in Australia
- Scientific Research Services in New Zealand
- Biotechnology in the UK
Table of Contents
About this industry
Industry definition
Animal health biotechnology companies research, develop, test and distribute therapeutic drugs, diagnostic tools and preventive products for livestock and companion animals. Drugs not developed using biological materials or processes are not included in this industry. In addition, companies provide tools that improve farm animal breeding programs.
What's included in this industry?
Developing animal vaccinesResearching and testing animal medicineDeveloping preventative care medicineDeveloping topical parasiticidePropagating livestock breedingEnsuring food safety through drug safetyResearching and developing animal cloning techniquesCompanies
Zoetis Inc.Merck & CoCH Boehringer Sohn AG & Ko. KGPurchase this report to view all 3 major companies in this industry.
Related Terms
TRANSGENICGENETIC ENGINEERINGCLONINGBIOPHARMACEUTICALPARASITICIDECOMPANION ANIMALBOVINE SPONGIFORM ENCEPHALOPATHYIndustry Code
NAICS 54171 - Animal Health Biotechnology in the US
Performance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
Animal health biotech companies are increasingly involved in safeguarding animal health. Pet owners and livestock producers are willing to pay a premium to improve the well-b...
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
Developments in vaccines and medications are transforming animal care. Animal health biotech companies are introducing innovative medications that are invaluable to veterinar...
In this chapter
- Products & Services
- Major Markets
- International Trade
Key metrics
- Largest market segment and value in 2024
- Product innovation level
- Total imports, level and trend
- Total exports, level and trend
- Trade Balance
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
- International trade, including imports by country and exports by country
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
- Recent trends in import and export volumes, country of origin or destination, and expected future trends
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
Mid-Atlantic states are biotech hubs. Animal health leaders Zoetis and Merck drive biotech activity in the region.
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each state
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each state in 2024
- Number and share of revenue each state accounts for in 2024
- Number and share of wages each state accounts for in 2024
- Number and share of employees in each state in 2024
Detailed analysis
- Geographic spread of the industry across North America, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
Patent protection limits price competition. Biotechnology companies with patent protection receive market exclusivity for their product, granting them pricing power.
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry’s own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
Zoetis is at the forefront of animal health. The company has introduced over 5,000 patent-protected breakthrough animal products to the animal health market, leading it to do...
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
- Overview of Zoetis Inc.'s performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Merck & Co's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of CH Boehringer Sohn AG & Ko. KG's performance by revenue, market share and profit margin from 2018 through 2024
Detailed analysis
- Description and key data for Zoetis Inc., and factors influencing its performance in the industry
- Description and key data for Merck & Co, and factors influencing its performance in the industry
- Description and key data for CH Boehringer Sohn AG & Ko. KG, and factors influencing its performance in the industry
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Analyst insights
Animal health biotechs navigate a complex regulatory environment. A collection of federal agencies and regulatory bodies oversee the safety and efficacy of developing biotech...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)
- Assistance historical data and forecast (2014-2029)
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Analyst insights
Animal health biotechnology R&D is a knowledge-intensive process. Wages are a leading expense for companies competing for top talent in sophisticated fields.
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Industry Multiples (2017-2022)
- Industry Tax Structure (2017-2022)
- Income Statement (2017-2022)
- Balance Sheet (2017-2022)
- Liquidity Ratios (2017-2022)
- Coverage Ratios (2017-2022)
- Leverage Ratios (2017-2022)
- Operating Ratios (2017-2022)
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Methodology
How are IBISWorld reports created?
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do IBISWorld analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
- US Census Bureau
- US Bureau of Labor Statistics
- US International Trade Commission
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does IBISWorld forecast its data?
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Frequently Asked Questions
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Animal Health Biotechnology in the US industry in United States in 2024?
The market size of the Animal Health Biotechnology in the US industry in United States is $14.0bn in 2024.
How many businesses are there in the Animal Health Biotechnology in the US industry in 2024?
There are 197 businesses in the Animal Health Biotechnology in the US industry in United States, which has grown at a CAGR of 4.1 % between 2019 and 2024.
Has the Animal Health Biotechnology in the US industry in United States grown or declined over the past 5 years?
The market size of the Animal Health Biotechnology in the US industry in United States has been growing at a CAGR of 3.1 % between 2019 and 2024.
What is the forecast growth of the Animal Health Biotechnology in the US industry in United States over the next 5 years?
Over the next five years, the Animal Health Biotechnology in the US industry in United States is expected to grow.
What are the biggest companies in the Animal Health Biotechnology in the US market in United States?
The biggest companies operating in the Animal Health Biotechnology market in United States are Zoetis Inc., Merck & Co and CH Boehringer Sohn AG & Ko. KG
What does the Animal Health Biotechnology in the US in United States include?
Developing animal vaccines and Researching and testing animal medicine are part of the Animal Health Biotechnology in the US industry.
Which companies have the highest market share in the Animal Health Biotechnology in the US in United States?
The company holding the most market share in United States is Zoetis Inc..
How competitive is the Animal Health Biotechnology in the US industry in United States?
The level of competition is moderate and increasing in the Animal Health Biotechnology in the US industry in United States.
